Impact of fecal occult blood on obscure gastrointestinal bleeding: Observational study

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 1

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jan 7, 2015; 21(1): 326-332
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.326

Table 5 Univariate analysis of predictive factors for small bowel diseases in patients with obscure gastrointestinal bleeding

Factor	OR	95%CI	P value
Age (yr)
> 64	1.2	0.67-2.2	0.52
≤ 64	1
Sex
Male	1
Female	1.1	0.61-2.0	0.75
FOBT
Positive	2.5	1.4-4.5	0.002
Negative	1
OGIB
Overt	1.4	0.78-2.5	0.27
Occult	1
Hemoglobin (g/dL)
≤ 10.6	1.5	0.81-2.6	0.21
> 10.6	1
Medication
NSAIDs	0.67	0.23-2.0	0.47
Aspirin and/or other anticoagulants	0.83	0.45-1.6	0.57

FOBT: Fecal occult blood test; OGIB: Obscure gastrointestinal bleeding; NSAIDs: Non-steroidal anti-inflammatory drugs; CI: Confidence interval.

Citation: Kobayashi Y, Watabe H, Yamada A, Suzuki H, Hirata Y, Yamaji Y, Yoshida H, Koike K. Impact of fecal occult blood on obscure gastrointestinal bleeding: Observational study. World J Gastroenterol 2015; 21(1): 326-332
URL: https://www.wjgnet.com/1007-9327/full/v21/i1/326.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i1.326

Kobayashi Y, Watabe H, Yamada A, Suzuki H, Hirata Y, Yamaji Y, Yoshida H, Koike K. Impact of fecal occult blood on obscure gastrointestinal bleeding: Observational study. World J Gastroenterol 2015; 21(1): 326-332 [PMID: 25574108 DOI: 10.3748/wjg.v21.i1.326]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.